Clinical Trial Update: Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial of vemurafenib for locally advanced thyroid cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Vemurafenib (vemurafenib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Thyroid Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING